Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
J&J bispecific combo delivers 89% PFS benefit in myeloma
An 89% progression-free survival improvement and a 62% overall survival benefit topline Tecvayli and Talvey’s MonumenTAL-6 readout in earlier myeloma.
Angus Liu
Jul 23, 2026 8:30am
Access: A key driver of non-opioid pain management adoption
Brought to you by
Pacira BioSciences, Inc.
FDA panel favors peptides on 1st day of compounding adcomm
Jul 23, 2026 3:05pm
Roche defends 6B franc Vabysmo peak target despite another miss
Jul 23, 2026 11:32am
BeOne joins reshoring parade with $300M US production expansion
Jul 23, 2026 11:18am
Regulatory tracker: Europe signs off on AZ's camizestran
Jul 23, 2026 10:20am
More News
Fierce Biotech
Australia's Clinuvel to shed up to 20% of workforce in US move
Jul 23, 2026 5:47am
Fierce Biotech
How India can build on its budding innovative R&D moment: report
Jul 23, 2026 5:00am
ARS passes the ball to Drew Brees in Neffy awareness campaign
Jul 22, 2026 6:16pm
Nuvalent deal delivers GSK’s first-ever lung cancer approval
Jul 22, 2026 3:15pm
